Concepedia

Low dose intravenous cangrelor versus glycoprotein IIb/IIIa inhibitors in endovascular treatment of tandem lesions

Mouhammad Jumaa, Aarón Rodríguez-Calienes, Giana Dawod, Juan Vivanco‐Suarez, Ameer E Hassan, Afshin A. Divani, Marion Oliver, Marc Ribó, Nils Petersen, Michael Abraham,

Journal of Stroke and Cerebrovascular Diseases · 2023 · 18 citations · 24 references

DOIFull text

Open access

Concepts

References

24

Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

Werner Hacke, Markku Kaste, Erich Bluhmki et al. · New England Journal of Medicine · 2008 · 6.6K citations · Full text

, , +11

Negative Fluid-Attenuated Inversion Recovery- Based Intravenous Thrombolysis Using Recombinant Tissue Plasminogen Activator in Acute Stroke Patients with Unknown Onset Time

Junya Aoki, Kazumi Kimura, Kensaku Shibazaki et al. · Cerebrovascular Diseases Extra · 2013 · 1.9K citations · Full text

, , +17

The North American Symptomatic Carotid Endarterectomy Trial

Gary G. Ferguson, Michael Eliasziw, Hugh W. K. Barr et al. · Stroke · 1999 · 1.5K citations

, , +17

Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events

Deepak L. Bhatt, Gregg W. Stone, Kenneth W. Mahaffey et al. · New England Journal of Medicine · 2013 · 825 citations · Full text

, , +17

Low-Dose Tirofiban Improves Functional Outcome in Acute Ischemic Stroke Patients Treated With Endovascular Thrombectomy

Wenbo Zhao, Ruiwen Che, Shuyi Shang et al. · Stroke · 2017 · 170 citations · Full text

, , +17